Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 1

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Papillomavirus Infections 11Neoplasms 10Uterine Cervical Neoplasms 8Breast Neoplasms 8Condylomata Acuminata 5Prostatic Neoplasms 4Melanoma 4Anus Neoplasms 4Vulvar Neoplasms 3Uterine Cervical Dysplasia 3Lung Neoplasms 3Herpes Zoster 3Glioblastoma 3Carcinoma, Non-Small-Cell Lung 3Vaginal Neoplasms 2Sarcoma 2Neuroblastoma 2Neoplasm Metastasis 2Influenza, Human 2HIV Infections 2Glioma 2Colonic Neoplasms 2Breast Neoplasms, Male 2Wilms Tumor 1Whooping Cough 1Waldenstrom Macroglobulinemia 1Triple Negative Breast Neoplasms 1Tetanus 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1

Interventions

Vaccines 3Herpes Zoster Vaccine 2Mass Screening 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Herpes Zoster × Vaccines × Clear all
NCT01798056 2021-05-13

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy

GlaxoSmithKline

Phase 3 Completed
237 enrolled 20 charts

Herpes Zoster

NCT01254630 2019-09-30

V212-011

Merck Sharp & Dohme LLC

Phase 3 Completed
5,305 enrolled 20 charts
Other hematologic neoplasm

Herpes Zoster, Hematologic Neoplasms

NCT01460719 2019-03-11

V212-013

Merck Sharp & Dohme LLC

Phase 1 Completed
80 enrolled 13 charts

Herpes Zoster

Data powered by HemOnc (CC BY 4.0) Colophon âš¡